Search results for “Beta-adrenergic blocking agent” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 105 patents, we discovered top 29 key players by total patent application. Imperial Chemical Industries Ltd., elbion GmbH, Sandoz AG are dominant in this area. They take 32.38% of the total patent filing.
Imperial Chemical Industries Ltd.
United Kingdom
Patent: 19
elbion GmbH
Germany
Patent: 8
Sandoz AG
Switzerland
Patent: 7
Merck & Co., Inc.
New Jersey, United States
Patent: 6
American Hospital Supply Corp.
United States
Patent: 5
Ciba-Geigy AG
Switzerland
Patent: 3
Medichem SA
Spain
Patent: 3
University of Utah Research Foundation
Utah, United States
Patent: 3
DuPont Merck Pharmaceutical Co.
Delaware, United States
Patent: 3
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
No data, please try another search term
New Entrants
Order by:
Innovation in recent 5 years
No data, please try another search term
Research Institutions
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 3 universities and scientific research institutions by total patent application.
Nevada System of Higher Education
Nevada, United States
Patent: 3
The University of Nevada, Reno
Nevada, United States
Patent: 2
Boston University
Massachusetts, United States
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: